TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
MRVI

Maravai Lifesciences Holdings Inc

Healthcare · Biotechnology

7.70$ +3.8% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow MRVI
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – +531.1% +142.2% +45.4% -76.4% -94.1% -871.2%
– +7.8% +7.3% -4.2% +53.9% +28.0% +16.6% +6.3%
– -20.8% +1,366.9% -57.5% +78.5% +85.3% +42.9% -38.9%
– – -171.3% – +598.1% – – –
– – +1,467.4% -592.1% – – -112.9% –
– +374.9% +48.2% -41.6% +15.1% +283.6% -54.8% -55.7%
– +396.9% – +1,641.2% -353.3% -54.3% -80.1% +29.2%
– +86.4% +527.8% -74.8% – – – –
– +2,422.2% +642,182.8% – -100.0% – +10,310.0% –
– -104.8% – -103.0% -9.3% +6.1% +3,955.3% -97.7%
– -54.5% – -398.9% +17.9% -67.4% +285.8% -93.0%
– – +7,362.4% +49.0% -74.3% -170.7% – –
– – +1,719.7% +179.0% +46.7% -88.3% -136.6% –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?